Journal of Cardiovascular Pharmacology · 1994 · 63 citations · 0 references
Life SciencesCardiologyPharmacologyBiochemical PharmacologyCell SignalingSignal TransductionCalcium SignalingCardiac PhysiologyCardiovascular PathophysiologyCardiovascular PhysiologyCyclic Nucleotide SignalingAdenylate Cyclase RegulationAdenylate Cyclase SignalingAdenylyl Cyclase RegulationAdenylyl Cyclase SignalingCyclic Adenosine Monophosphate SignalingEndothelin Receptor SignalingInositol Phosphate SignalingInositol Triphosphate Signaling
To study signal transduction pathways of endothelin (ET) in human heart, we assessed, in isolated human right atria, the effects of ET-1 and ET-3 on inositol phosphate (IP) formation and on the adenylate cyclase/cyclic AMP system. In right atrial slices, ET-1 (10(-10)-10(-6)M) concentration-dependently increased [3H]IP accumulation and decreased 10-microM isoprenaline-induced or 1-microM forskolin-induced increases in cyclic AMP content. ET-3 was approximately 100 times less potent. The cyclic AMP-decreasing effect of ET-1 (10(-11)-10(-6)M) could also be demonstrated directly in adenylate cyclase assays in right atrial membranes; again, ET-3 was approximately 100 times less potent. We conclude that in human right atrium, ETA receptors couple to two different signal-transduction pathways: IP formation and inhibition of adenylate cyclase.